Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreatic Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · Pancreas Cancer · Pancreatic Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese PLA General Hospital, Beijing, China
Contact: Study coordinator (Ru Jia) · ashleyjr@163.com · +8613811721720
Contact: Study coordinator (Guanghai Dai)
Contact: Study coordinator (Quanli Han)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Phase 2 Study · BMS-986504 · MTAP-deleted Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Houston, United States

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Shanhai, China

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer

Abroad (travel likely)RecruitingPHASE2

Abbotsford, Australia · Northcote, Australia

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States